Drug-Drug Interaction (DDI) Study of ALXN2050 in Healthy Adult Participants
Condition: Healthy Interventions: Drug: ALXN2050; Drug: Cyclosporine; Drug: Tacrolimus; Drug: MMF Sponsor: Alexion Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 21, 2022 Category: Research Source Type: clinical trials